Truvada

Product NDC
63629-7581
11-digit product format
636297581
Labeler code
63629
Product ID
63629-7581_bfbe19cd-eb95-44b8-ad2e-34fb7f50d455
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
emtricitabine and tenofovir disoproxil fumarate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
NDA021752
Marketing category
NDA
Marketing start
2004-08-02
Marketing end
0000-00-00
Substance
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active strength
200 mg/1; mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
63629-7581-1636297581013 TABLET, FILM COATED in 1 BOTTLE (63629-7581-1) 2018-04-240000-00-00NoNoCurrent
63629-7581-2636297581027 TABLET, FILM COATED in 1 BOTTLE (63629-7581-2) 2018-04-240000-00-00NoNoCurrent
63629-7581-36362975810315 TABLET, FILM COATED in 1 BOTTLE (63629-7581-3) 2018-04-240000-00-00NoNoCurrent